- Home
- LGND
as 02-21-2025 4:00pm EST
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Upcoming Earnings Alert:
Get ready for potential market movements as Ligand Pharmaceuticals Incorporated LGND prepares to release earnings report on 27 Feb 2025.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 2.2B | IPO Year: | 1992 |
| Target Price: | $145.00 | AVG Volume (30 days): | 79.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.47 | EPS Growth: | 160.46 |
| 52 Week Low/High: | $67.72 - $129.90 | Next Earning Date: | 02-27-2025 |
| Revenue: | $152,422,000 | Revenue Growth: | -0.76% |
| Revenue Growth (this year): | 26.86% | Revenue Growth (next year): | 14.95% |
Latest Ligand Pharmaceuticals Incorporated News
LGND Breaking Stock News: Dive into LGND Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
LGND: Raising target price to $126.00
Business Wire
9 days ago
Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Business Wire
16 days ago
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Argus Research
17 days ago
LGND: Lowering target price to $123.00
Argus Research
24 days ago
LGND: Raising target price to $124.00
Argus Research
a month ago
LGND: Raising target price to $123.00
Argus Research
a month ago
LGND: Lowering target price to $114.00
Zacks Small Cap Research
a month ago
Zacks Small Cap Research 2024 Initiations and Best Ideas for 2025
Compare LGND vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LGND Ligand Pharmaceuticals Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.